InvestorsHub Logo
Followers 0
Posts 18
Boards Moderated 0
Alias Born 06/27/2017

Re: None

Tuesday, 08/01/2017 1:13:42 PM

Tuesday, August 01, 2017 1:13:42 PM

Post# of 3970
What are your thoughts on the upcoming ph 2 results for IBS-D?

Previous studies with ondansetron for IBS-D reached significant improving in stool consistency.

The same endpoint RDHL is using..
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News